Approval · Notice of Compliance 23735 · 2020
TUKYSA: Notice of Compliance 23735
Issued June 5, 2020
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 23735
- Date
- June 5, 2020
- Company
- Seattle Genetics Inc
- Product type
- Prescription Pharmaceutical
- Submission
- New Drug Submission (NDS)
- Submission class
- Priority-NAS